Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
Download a publication order form here or subscribe here.
MDL Mass Tort & Class Action Monitor - Issue: 47
New Tylenol MDL Plaintiffs Say Cases Not Affected by Expert Exclusion
Generic Drug Makers Ask JPML to Stay Remand Pending Venue Act Challenge to 3rd Cir.
JPML Centralizes Suboxone Film Dental Decay Lawsuits
JPML Creates MDL Docket for Federal Cases Involving GLP-1RA Drugs
Parties in Tepezza MDL Agree Upon Document Production Protocol
Novartis Denied Summary Judgment in Tasigna Cancer Drug MDL
Defendants’ Post-Verdict Motion Denied in Bellwether Davol/Bard Hernia Mesh Case
Plaintiff May Amend Consumer Deception Claims in ‘Keto-Friendly’ Cereal Class Action
